Skip to main content

Illumina to Handle Genotyping for Two Large Cancer Research UK Projects

NEW YORK (GenomeWeb News) — Illumina will use its Infinium and Beadchip tools to genotype more than 15,000 samples for lung and ovarian cancer research studies organized by Cancer Research UK, the company said today.
 
For the program to discover genetic risk factors to lung cancer, Illumina will run more than 2,000 samples on the HumanHap550 Beadchip and 5,600 samples on an iSelect Custom Beadchip for the University of Cambridge.
 
In the ovarian cancer study, conducted for the University of Cambridge and the University of London, Illumina will process more than 2,000 samples on the HumanHap550 and 6,000 samples on the iSelect, the company said.
 
Illumina said the programs are the third and fourth for which it has been asked to contribute for Cancer Research UK.
 
Financial terms of the studies, both of which will be funded by Cancer Research UK, were not released.  

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.